Group Telehealth Behavioral Cough Suppression Therapy

Part of paid clinical trials in Missoula, Montana.

Sponsor
University of Montana
Study ID
NCT06706765
Phase
EARLY_PHASE1
Status
Recruiting

Conditions

  • Refractory Chronic Cough

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Behavioral Treatment — BEHAVIORAL
    Behavioral cough suppression therapy delivered in a group setting via telehealth.

Study Details

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Key Dates

Start date
Mar 22, 2024
Status verified
Aug 2024
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Group Telehealth Behavioral Cough Suppression Therapy

Primary Outcome Measure

Leicester Cough Questionnaire [ Time Frame: Baseline, one-week post-treatment, and one-month post-treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MontanaMissoulaMontana59812
Jane E Reynolds, PhD
406-243-2138
Laurie J Slovarp, PhD
406-243-2107
Laurie J Slovarp, PhD
Jane E Reynolds, PhD

Find similar trials in Missoula, MT

Related Studies